Gazyva Approved for Certain Patients with Follicular Lymphoma
March 1st 2016The FDA has approved Roche's obinutuzumab, plus bendamustine chemotherapy, followed by Gazyva alone, as a new treatment option for patients with follicular lymphoma who did not respond to a previous regimen containing rituximab.
Read More